EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Cardioprotective Diet to Prevent Anthracycline-Induced Cardiotoxicity in Patients with Breast Cancer: A Randomized Open-Label Controlled Trial

Azin Alizadehasl, Mona Malekzadeh Moghani, Hamidreza Mirzaei, Masoumeh Keshvari, Fatemeh Fadaei, Holger Cramer iD, Mehdi Pasalar iD, Ghazaleh Heydarirad iD

Journal of Integrative and Complementary Medicine · 2024

DOI: 10.1089/jicm.2023.0777 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Integrative and Complementary Medicine, 2024. Verfasst von Azin Alizadehasl und 7 weiteren Autor:innen. Beteiligte Einrichtung: Cardio-Oncology Research Center, Rajaie Cardiovascular Medical & Research Center, Iran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Anthracyclines, Breast Neoplasms, Cardiotoxicity, Cardiotonic Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Several studies have indicated that dietary interventions may offer protection against the development of cardiac damage in the case of anthracycline-induced cardiomyopathy (AIC). The goal of this study was to assess whether an evidence-based cardioprotective diet can be effective in preventing AIC in patients with breast cancer.

Design

Randomized, open-label, controlled trial. The study period was set for 18 weeks, and the data were analyzed by generalized estimating equation modeling and one-way repeated measures analysis of variance. Setting/Location: Shahid Rajaie Hospital affiliated (Tehran, Iran). Subjects: Fifty anthracycline-treated patients with breast cancer.

Interventions

Patients were randomized to receive either a 2-hour training in evidence-based cardio-protective diet or Carvedilol 6.25 mg bid. Outcome Measures: The primary outcome was the number of patients with abnormal left ventricular ejection fraction (LVEF) after 18 weeks.

Results

At week 18, 12 (48%) out of 25 participants in the cardioprotective diet group had abnormal LVEF in comparison with 21 (84%) out of 25 in the carvedilol group ( p = 0.007). Also, 2 (8%) out of 25 in the cardioprotective diet group compared with 7 (28%) out of 25 participants in the carvedilol group had abnormal global longitudinal strain ( p = 0.066). The diet group showed significant improvements in the quality-of-life dimensions named “health change” and “general health” compared with the carvedilol group using the Short Form-36 Health Survey questionnaire.

Conclusions

This study suggests that an evidence-based cardioprotective diet can contribute to the prevention of AIC. Although current treatments for AIC can be effective, further research is mandatory for more options.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnthracyclinesBreast NeoplasmsCardiotoxicityCardiotonic AgentsAdultFemaleHumansMiddle AgedCardiomyopathiesCarvedilolIran

Stichwörter der Autor:innen

anthracyclinebreast cancercardioprotectivecarvediloldietheart

Substanzen

AnthracyclinesCarvedilolCardiotonic Agents

Autor:innen und Institutionen

  • Cardio-Oncology Research Center, Rajaie Cardiovascular Medical & Research Center, Iran University of Medical Sciences, Tehran, Iran.
  • Shohada-e Tajrish Hospital, Department of RadioOncology, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Cancer Research Center, Shohadae Tajrish Hospital, Department of Radiation Oncology, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Clinical Research Development Center, Mahdiyeh Educational Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Department of Traditional Medicine, School of Traditional Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Institute for General Practice and Interprofessional Care, Tuebingen, University Hospital Tuebingen, Tuebingen, Germany.

ORCID-Profile: Holger Cramer, Mehdi Pasalar, Ghazaleh Heydarirad

Zitieren

APA

Alizadehasl, A., Malekzadeh Moghani, M., Mirzaei, H., Keshvari, M., Fadaei, F., Cramer, H., Pasalar, M., & Heydarirad, G. (2024). Cardioprotective Diet to Prevent Anthracycline-Induced Cardiotoxicity in Patients with Breast Cancer: A Randomized Open-Label Controlled Trial. Journal of Integrative and Complementary Medicine. https://doi.org/10.1089/jicm.2023.0777

Vancouver

Alizadehasl A, Malekzadeh Moghani M, Mirzaei H, Keshvari M, Fadaei F, Cramer H, et al. Cardioprotective Diet to Prevent Anthracycline-Induced Cardiotoxicity in Patients with Breast Cancer: A Randomized Open-Label Controlled Trial. Journal of Integrative and Complementary Medicine. 2024. doi:10.1089/jicm.2023.0777

BibTeX
@article{Alizadehasl2024,
  author = {Alizadehasl, Azin and Malekzadeh Moghani, Mona and Mirzaei, Hamidreza and Keshvari, Masoumeh and Fadaei, Fatemeh and Cramer, Holger and Pasalar, Mehdi and Heydarirad, Ghazaleh},
  title = {Cardioprotective Diet to Prevent Anthracycline-Induced Cardiotoxicity in Patients with Breast Cancer: A Randomized Open-Label Controlled Trial},
  journal = {Journal of Integrative and Complementary Medicine},
  year = {2024},
  doi = {10.1089/jicm.2023.0777}
}
Kostenlos starten →